Similarity is based on the correlation of the price action of the past 100 trading sessions.
The reference chart (PTPI) is shown first. Other charts are sorted by their correlation and the most similar chart is ranked highest.
Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics in the United States and internationally.
It operates through two segments, Prescription Medications and Medical Devices.
The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED).
It also develops and commercializes H100, a novel and patented topical formulation candidate for the treatment of acute Peyronie's disease.
The company offers men's health products, including vacuum erection devices, penile injections, PreBoost, VenoSeal, and urinary tract infection tests for the treatment of erectile dysfunction.
Petros Pharmaceuticals, Inc. is based in New York, New York.
This website uses cookies. To learn more about cookies, please see our privacy policy .